BA
GENE

Ballew Advisors’s Genetic Technologies Ltd. GENE Stock Holding History

Ballew Advisors’s Portfolio GENE Stock Details GENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-95
Closed -$2K – 465
2018
Q3 		$2K Buy
+95
New +$2K ﹤0.01% 416